Cataloguing the postnatal small intestinal transcriptome during the first postnatal month

Reviewer #1 (Public review):

Summary:

In this manuscript, the authors aimed to clarify the transcriptional changes across murine postnatal small intestinal development (0 days to 1 month) in both the duodenum and ileum, a period that shows morphological similarity to 20-30 week old fetal humans. This is an especially critical stage in human intestinal development, as necrotizing enterocolitis (NEC) usually manifests during these stages.

Strengths:

The authors assessed numerous timepoints between 0 days and 1 month in the postnatal mouse duodenum and ileum using bulk RNA transcriptomics of bulk-isolated tissues. Cellular deconvolution, based on relative marker expression, was used to clarify immune cell proportions in the bulk RNA sequencing data. They confirmed some transcriptional targets found in vivo primarily in mouse via qrtPCR and immunohistochemistry, but also in human fetal tissues and isolated organoids, and are of decent quality.

Weaknesses:

The overall weakness of this study, as mentioned by the authors themselves, is that the bulk transcriptomic data generated for the study were isolated from non-fractionated bulk intestinal tissue. This makes it difficult to interpret much of this data regarding cellular fractions found across developmental time. It is difficult to rationalize the approach here, as even isolation protocols of epithelial-only or mesenchyme-only tissues for bulk RNA sequencing are well established. The authors address some of these concerns using cellular deconvolution for immune cell populations, which I think might be helpful if they expanded this analysis to other cell types (mesenchyme, endothelium, glia). However, I would assume that bulk isolations across developmental time are going to be influenced primarily by the bulk of tissue-type found at each time point - primarily epithelium. But this is also confirmed by the immune transcripts becoming more apparent later in their time series, as this system becomes more established during weaning. This study might also be strengthened by comparison with data that is publicly available for early fetal stage development in humans. Comparisons between the duodenum and ileum could be strengthened by what we already know from adult data, from both epithelial- and mesenchyme-isolated fractions. The rationale of using the postnatal mouse as a comparison to NEC is also a little unclear- perhaps some of the developmental processes are similar, however, the environments are completely different. For example, even in early postnatal mouse development, you would find microbial activity and milk.

Reviewer #2 (Public review):

Summary:

This work presents a valuable resource by generating a comprehensive bulk RNA sequencing catalogue of gene expression in the mouse duodenum and ileum during the first postnatal month. The central findings of this work are based on an analysis of this dataset. Specifically, the authors characterized molecular shifts that occur as the intestine matures from an immature to an adult-like state, investigating both temporal changes and regional differences between the proximal and distal small intestine. A key objective was to identify gene expression patterns relevant to understanding the region-specific susceptibility and resistance to necrotizing enterocolitis (NEC) observed in humans during the postnatal period. They also sought to validate key findings through complementary methods and to provide comparative context with human intestinal samples. This study will provide a solid reference dataset for the community of researchers studying postnatal gastrointestinal development and diseases that arise during these stages. However, the study lacks functional validation of the interpretations.

Strengths:

(1) The inclusion of numerous time points (day 0 through 4 weeks) and comparative analyses throughout the first postnatal month.

(2) Validation of key interpretations of RNA-seq data by other methods.

(3) Linking mouse postnatal development to human premature infant development, enhancing its clinical relevance, particularly for NEC research. The inclusion of human intestinal biopsy and organoid data for comparison further strengthens this link.

(4) The investigation covers a wide array of developmental gene categories with known significance, including epithelial differentiation markers (e.g., Vil1, Muc2, Lyz1), intestinal stem cell markers (e.g., Lgr5, Olfm4, Ascl2), mesenchymal markers (e.g., Pdgfra, Vim), Wnt signaling components (e.g., Wnt3, Wnt5a, Ctnnb1), and various immune genes (e.g., defensins, T cell, B cell, ILC, macrophage markers).

Weaknesses:

(1) The primary limitation is that there is no functional validation. The study primarily focuses on the interpretation of RNA expression. This is a common limitation of transcriptomic "atlas" studies, but the functional and mechanistic relevance of these interpretations remains to be determined.

(2) The data are derived from bulk RNA-Seq of full-thickness intestinal tissue. While this approach helps capture rare cell types and both epithelial and mesenchymal components simultaneously, it does not provide cell-type-specific gene expression profiles, which might obscure important nuances. Future investigations using single-cell sequencing would be a logical follow-up.

(3) The day 4 samples were omitted due to quality issues, which might have led to missing some dynamic changes, especially given that some ISC genes show dynamic changes around day 6.

Reviewer #3 (Public review):

Summary:

This study uses bulk mRNA sequencing to profile transcriptional changes in intestinal cells during the early postnatal period in mice - a developmental window that has received relatively little attention despite its importance. This developmental stage is particularly significant because it parallels late gestation in humans, a time when premature infants are highly vulnerable to necrotizing enterocolitis (NEC). By sampling closely spaced timepoints from birth through postnatal week four, the authors generate a resource that helps define transcriptional trajectories during this phase. Although the primary focus is on murine tissue, the authors also present limited data from human fetal intestinal biopsy samples and organoids. In addition, they discuss potential links between observed gene expression changes and factors that may contribute to NEC.

Strengths:

The close temporal sampling in mice offers a detailed view of dynamic transcriptional changes across the first four weeks after birth. The authors leverage these close timepoints to perform hierarchical clustering to define relationships between developmental stages. This is a useful approach, as it highlights when transcriptional states shift most dramatically and allows for functional predictions about classes of genes that vary over time. This high-level analysis provides an effective entry point into the dataset and will be useful for future investigations. The inclusion of human fetal intestinal samples, although limited, is especially notable given the scarcity of data from late fetal timepoints. The authors are generally careful in their presentation of results, acknowledging the limitations of their approach and avoiding over-interpretation. As they note, this dataset is intended as a foundation for their lab and others, with secondary approaches required to more fully explore the biological questions raised.

Weaknesses:

One limitation of the study is the use of bulk mRNA sequencing to draw conclusions about individual cell types. It has been documented that a few genes are exclusively expressed in single cell types. For instance, markers such as Lgr5 and Olfm4 are enriched in intestinal stem cells (ISCs), but they are also expressed at lower levels in other lineages and in differentiating cells. Using these markers as proxies for specific cell populations lowers confidence in the conclusions, particularly without complementary validation to confirm cell type-specific dynamics.

Validation of the sequencing data was itself limited, relying primarily on qPCR, which measures expression at the same modality rather than providing orthogonal support. It is unclear how the authors selected the subset of genes for validation; many key genes highlighted in the sequencing data were not assessed. Moreover, the regional differences reported in Lgr5, Olfm4, and Ascl2, appearing much higher in proximal samples than in distal ones, were not recapitulated by qPCR validation of Olfm4, and this discrepancy was not addressed. Resolving such inconsistencies will be important for interpreting the dataset.

The basis for linking particular gene sets to NEC susceptibility rests largely on their spatial restriction to the distal intestine and their temporal regulation between early (day 0-14) and later (weeks 3-4) developmental stages. While this is a reasonable approach for generating hypotheses, the correlations have limited interpretive power without experimental validation, which is not provided here. Many factors beyond NEC may drive regional and temporal differences in intestinal development.

Finally, the contribution of human fetal biopsy samples is minimal. The central figure presenting these data (Figure 4A) shows immunofluorescence for LGR5, a single stem cell marker. The staining at day 35 is not convincing, and the conclusions that can be drawn are limited to confirming the localization of LGR5-positive cells to crypts as early as 26 weeks.